Cart
sales@molnova.com
RORγ inverse agonist 1
CAS No. 529500-72-9
RORγ inverse agonist 1( —— )
Catalog No. M36101 CAS No. 529500-72-9
RORγ inverse agonist 1 has anti-inflammatory activity and can be used to treat rheumatism and psoriasis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 45 | In Stock |
|
| 10MG | 72 | In Stock |
|
| 25MG | 116 | In Stock |
|
| 50MG | 172 | In Stock |
|
| 100MG | 250 | In Stock |
|
| 500MG | 609 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRORγ inverse agonist 1
-
NoteResearch use only, not for human use.
-
Brief DescriptionRORγ inverse agonist 1 has anti-inflammatory activity and can be used to treat rheumatism and psoriasis.
-
DescriptionRORγ inverse agonist 1 is the inverse agonist of RORγ.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number529500-72-9
-
Formula Weight463.47
-
Molecular FormulaC22H20F3N3O3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESN(S(=O)(=O)C1=CC=C(C)C=C1)(CC(NCC=2C=CN=CC2)=O)C3=CC(C(F)(F)F)=CC=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Song Y, et al. Identification of N-phenyl-2-(N-phenylphenylsulfonamido)acetamides as new RORγ inverse agonists: Virtual screening, structure-based optimization, and biological evaluation. Eur J Med Chem. 2016 Jun 30;116:13-26.?
molnova catalog
related products
-
[Asp371]-Tyrosinase ...
Tyrosinase (369-377,YMDGTMSQV) is derived from the membrane protein tyrosinase by posttranslational conversion of the sequence YMNGTMSQV. Presentation of YMDGTMSQV in cells expressing full-length tyrosinase is TAP-(transporter associated with antigen processing) and proteosome-dependent.
-
Emedastine
Emedastine is a second generation, selective histamine H1 receptor antagonist with anti-allergic activity.
-
Zedoarondiol
Zedoarondiol has anti-inflammatory activity, inhibits iNOS, COX-2, and pro-inflammatory cytokine expressions by suppressing the phosphorylations of IKK and MAPKs, and by subsequently inactivating the NF-kappaB pathway.
